van Es Charles 4
4 · Vita Coco Company, Inc. · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) CCO Charles van Es Sells 8,045 Shares
What Happened
Charles van Es, Chief Commercial Officer of Vita Coco Company, Inc. (COCO), disposed of 8,045 shares of common stock on June 1, 2026, at $75.05 per share, generating gross proceeds of approximately $603,777. The sale is reported as an open-market/private sale and was executed pursuant to a Rule 10b5-1 trading plan.
Key Details
- Transaction date and price: June 1, 2026 — 8,045 shares sold at $75.05 per share (total ≈ $603,777)
- Transaction type/code: Sale (S) — open market or private sale
- Shares owned after transaction: Not specified in the Form 4 filing provided
- Notable footnote(s): F1 — sale effected pursuant to a Rule 10b5-1 trading plan. The filing also includes multiple footnotes (F2–F8) describing stock option vesting schedules; notably F5 indicates a performance-based option vested as to 14,025 shares on Feb 20, 2026.
- Timeliness: Report period 2026-06-01; filing dated 2026-06-02 — no late filing indicated.
Context
Sales made under Rule 10b5-1 plans are typically prearranged and can be used for routine liquidity, tax planning, or diversification; they do not necessarily reflect new private views on the company. For retail investors, purchases tend to be more informative than scheduled sales. This Form 4 reports a straightforward disposition of common stock (code S) rather than an option exercise or award grant.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-06-01$75.05/sh−8,045$603,777→ 59,085 total
- 53,750
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $10.18Exp: 2030-02-10→ Common Stock (53,750 underlying) - 27,300
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $10.18Exp: 2031-01-11→ Common Stock (27,300 underlying) - 58,043
Non-Qualified Stock Option (Right to Buy)
[F3]Exercise: $15.00Exp: 2031-10-21→ Common Stock (58,043 underlying) - 42,980
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $15.36Exp: 2032-08-15→ Common Stock (42,980 underlying) - 14,025
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,025 underlying) - 14,205
Non-Qualified Stock Option (Right to Buy)
[F6]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,205 underlying) - 8,746
Non-Qualified Stock Option (Right to Buy)
[F7]Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying) - 13,218
Non-Qualified Stock Option (Right to Buy)
[F8]Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
Footnotes (8)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option is fully vested and currently exercisable.
- [F3]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F4]The stock option vests in three equal annual installments beginning on August 15, 2025.
- [F5]The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
- [F6]The stock options vest in four annual equal installments beginning on March 10, 2024.
- [F7]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F8]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.